Literature DB >> 1299460

Measurement of quality of life in patients: psychometric analyses of the Functional Living Index-Cancer (FLIC).

G R Morrow1, J Lindke, P Black.   

Abstract

Biomedical advances in medical care and treatment have highlighted potential trade-offs between the length and quality of a patient's life. There is increasing need for psychometrically sound measurement of quality of life in medical patients. Psychometric analyses of the Functional Living Index-Cancer (FLIC) were conducted on data from 530 consecutive patients with histologically confirmed cancer. To examine construct validity, a principal components analysis was conducted that revealed a five-factor solution accounting for 70% of the variance in a random half of the original sample and 68% in a cross-replication sample. Content analysis indicated that domains of physical, psychological and social functioning are assessed along with the patient's view of their current well-being and disease symptoms. Convergent-discriminant validity was shown with independent measures of symptoms and anxiety. Most, but not all expected differences in quality of life by demographic and psychological variables were found. Within the limitations imposed by the study and its sample, the FLIC appears to be a conceptually sound, internally consistent instrument worthy of use and further study in other health care samples.

Entities:  

Mesh:

Year:  1992        PMID: 1299460     DOI: 10.1007/bf00434942

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  26 in total

Review 1.  Generic and disease-specific measures in assessing health status and quality of life.

Authors:  D L Patrick; R A Deyo
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

2.  A modular approach to quality-of-life assessment in cancer clinical trials.

Authors:  N K Aaronson; M Bullinger; S Ahmedzai
Journal:  Recent Results Cancer Res       Date:  1988

3.  The MOS short-form general health survey. Reliability and validity in a patient population.

Authors:  A L Stewart; R D Hays; J E Ware
Journal:  Med Care       Date:  1988-07       Impact factor: 2.983

4.  Measuring quality of life: risks and benefits.

Authors:  H Schipper; M Levitt
Journal:  Cancer Treat Rep       Date:  1985-10

5.  Anticipatory nausea development in cancer patients: replication and extension of a learning model.

Authors:  G R Morrow; J Lindke; P M Black
Journal:  Br J Psychol       Date:  1991-02

6.  Development of brief measures of psychological adjustment to medical illness applied to cancer patients.

Authors:  G R Morrow; M Feldstein; L M Adler; L R Derogatis; A J Enelow; C Gates; J Holland; N Melisaratos; B J Murawski; D Penman; A Schmale; M Schmitt; I Morse
Journal:  Gen Hosp Psychiatry       Date:  1981-06       Impact factor: 3.238

7.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

Authors:  H Schipper; J Clinch; A McMurray; M Levitt
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

8.  Methodology in behavioral and psychosocial cancer research. The assessment of nausea and vomiting. Past problems, current issues and suggestions for future research.

Authors:  G R Morrow
Journal:  Cancer       Date:  1984-05-15       Impact factor: 6.860

9.  Quality of life assessment of patients in extremity sarcoma clinical trials.

Authors:  P H Sugarbaker; I Barofsky; S A Rosenberg; F J Gianola
Journal:  Surgery       Date:  1982-01       Impact factor: 3.982

Review 10.  Methodologic issues in assessing the quality of life of cancer patients.

Authors:  N K Aaronson
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

View more
  13 in total

Review 1.  Measuring the effect of cancer on health-related quality of life.

Authors:  D Osoba
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

2.  Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma.

Authors:  D Osoba; N K Aaronson; M Muller; K Sneeuw; M A Hsu; W K Yung; M Brada; E Newlands
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

3.  The Functional Living Index-Cancer is a reliable and valid instrument in Chinese cancer patients.

Authors:  Daniel Y T Fong; Alvina H K Lee; Stewart Y Tung; Janet Y H Wong; Y M Chan; Cynthia R Goh; Y B Cheung
Journal:  Qual Life Res       Date:  2013-06-18       Impact factor: 4.147

Review 4.  Evaluation of quality of life for diverse patient populations.

Authors:  K R Yabroff; B P Linas; K Schulman
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 5.  Quality of life measures in cancer chemotherapy: methodology and implications.

Authors:  P A Ganz
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

6.  Minimal limb volume change has a significant impact on breast cancer survivors.

Authors:  J N Cormier; Y Xing; I Zaniletti; R L Askew; B R Stewart; J M Armer
Journal:  Lymphology       Date:  2009-12       Impact factor: 1.286

7.  Cost effectiveness analysis of intravenous ketorolac and morphine for treating pain after limb injury: double blind randomised controlled trial.

Authors:  T H Rainer; P Jacobs; Y C Ng; N K Cheung; M Tam; P K Lam; R Wong; R A Cocks
Journal:  BMJ       Date:  2000-11-18

8.  Validity, reliability and clinical relevance of EORTC QLQ-C30 and LC13 in patients with chest malignancies in a palliative setting.

Authors:  Mercedes Nicklasson; Bengt Bergman
Journal:  Qual Life Res       Date:  2007-05-04       Impact factor: 4.147

9.  The Functional Living Index-Cancer: estimating its reliability based on clinical trial data.

Authors:  Annouschka Laenen; Ariel Alonso
Journal:  Qual Life Res       Date:  2010-02       Impact factor: 4.147

Review 10.  Quality of life after allogeneic hematopoietic cell transplantation.

Authors:  Joseph Pidala; Claudio Anasetti; Heather Jim
Journal:  Blood       Date:  2009-03-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.